Scinai Immunotherapeutics Ltd's ROA from the fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Scinai Immunotherapeutics Ltd's ROA in the fourth quarter of 2025?
Scinai Immunotherapeutics Ltd recorded a cumulative net loss of $-8 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -49.06%.

However, within the Healthcare sector 747 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 4810.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Total Assets Change	181.47 %	-20.6 %	-68.85 %	-38.87 %	-30.89 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-8	7	7	7	7
Return On Assets (TTM)	-49.06 %	58.48 %	55.3 %	35.53 %	32.7 %
SCNI's Total Ranking	# 4810	#	#	#	#
Total Assets (TTM) in million	36	10	12	10	13
Seq. Total Assets Change	266.62 %	-16.83 %	19.03 %	-22.45 %	3.42 %
Seq. Net Income Change	-	-	-	-	-

SCNI's 5 Years Annual ROA >> Back to SCNI Management Effectiveness >> Compare SCNI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 114
Sector	# 748
Overall	# 4769

Return On Assets Statistics
High	Average	Low
37.2 %	-17.12 %	-71.45 %
(Dec 31 2023)		(Dec 31 2025)

Financial Statements
Scinai Immunotherapeutics Ltd's Assets	$ 36 million	SCNI's Balance sheet
Scinai Immunotherapeutics Ltd's Income	$ -8 million	Quarterly SCNI's Income Statement
SCNI's Income by Division		See SCNI's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2023) FY 2023	FY	FY	FY
Y / Y Total Assets Change	337.11 %	-55.5 %	-21.79 %	33.9 %	-47.03 %
Total Assets in million	36	8	19	24	18
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-8	7	0	0	0
Annual Return On Assets	-23.01 %	78.7 %	-	-	-

SCNI's 5 Years Annual ROA >> Back to SCNI Management Effectiveness >> Compare SCNI ROA to its Competitors

More Return On Assets Ratios
SCNI's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SCNI's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SCNI's Competitors
Subscribers only: Roa for Scinai Immunotherapeutics Ltd's Suppliers
Subscribers only: Return On Assets for SCNI's Customers

You may also want to know
SCNI's Roi	SCNI's Inventory Turnover Ratio	SCNI's Growth Rates	SCNI's Dividend Comparisons
	SCNI's Profitability Ratios	SCNI's Asset Turnover Ratio	SCNI's Dividend Growth
SCNI's Roe	SCNI's Valuation Ratios	SCNI's Financial Strength Ratios	SCNI's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector

ROA

Date modified: 2026-07-07T13:25:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.